3 hours Is This a New Reason to Buy Pfizer Stock Hand Over Fist?The Motley Fool
Despite Pfizer’s (NYSE: PFE) recent struggles with falling earnings and a bid by an activist investor to unseat its leadership, the pharma juggernaut is still actively advancing its core priorities and giving investors plenty of reasons to consider buy…
Earnings · NYSE · Pfizer (PFE)
X